Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer

343

Citations

15

References

2000

Year

Alan N. Gordon, C.O. Granai, Peter G. Rose, John D. Hainsworth, A. B. Lopez, Charles Weissman, Rosemary Rosales, Tim Sharpington

Journal of Clinical Oncology

Abstract

Stealth liposomal doxorubicin has activity in refractory epithelial ovarian cancer. PPE and stomatitis can usually be managed by dose adjustment. The ease of administration makes this an attractive agent.

References

	Year	Citations

Page 1